nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—atherosclerosis—abdominal aortic aneurysm	0.975	1	CtDrD
Lovastatin—ITGAL—connective tissue—abdominal aortic aneurysm	0.00142	0.101	CbGeAlD
Lovastatin—UGT1A1—blood plasma—abdominal aortic aneurysm	0.00111	0.0785	CbGeAlD
Lovastatin—ITGAL—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—SELL—abdominal aortic aneurysm	0.00103	0.0929	CbGpPWpGaD
Lovastatin—HMGCR—blood plasma—abdominal aortic aneurysm	0.000962	0.0682	CbGeAlD
Lovastatin—ITGAL—spinal cord—abdominal aortic aneurysm	0.000941	0.0667	CbGeAlD
Lovastatin—HMGCR—SREBF and miR33 in cholesterol and lipid homeostasis—LDLR—abdominal aortic aneurysm	0.000938	0.0848	CbGpPWpGaD
Lovastatin—SLCO1B1—blood plasma—abdominal aortic aneurysm	0.000921	0.0653	CbGeAlD
Lovastatin—ITGAL—Cell surface interactions at the vascular wall—SELL—abdominal aortic aneurysm	0.000778	0.0704	CbGpPWpGaD
Lovastatin—HMGCR—Statin Pathway—LRP1—abdominal aortic aneurysm	0.000769	0.0696	CbGpPWpGaD
Lovastatin—CYP2C19—blood plasma—abdominal aortic aneurysm	0.0006	0.0425	CbGeAlD
Lovastatin—UGT2B7—kidney—abdominal aortic aneurysm	0.00059	0.0418	CbGeAlD
Lovastatin—HMGCR—Statin Pathway—LDLR—abdominal aortic aneurysm	0.000583	0.0527	CbGpPWpGaD
Lovastatin—HDAC2—connective tissue—abdominal aortic aneurysm	0.000567	0.0402	CbGeAlD
Lovastatin—CYP2C8—blood plasma—abdominal aortic aneurysm	0.000524	0.0371	CbGeAlD
Lovastatin—HMGCR—connective tissue—abdominal aortic aneurysm	0.000512	0.0363	CbGeAlD
Lovastatin—UGT1A1—kidney—abdominal aortic aneurysm	0.000502	0.0356	CbGeAlD
Lovastatin—HDAC2—kidney—abdominal aortic aneurysm	0.000483	0.0342	CbGeAlD
Lovastatin—ITGAL—Extracellular matrix organization—ELN—abdominal aortic aneurysm	0.000482	0.0436	CbGpPWpGaD
Lovastatin—CYP3A5—blood plasma—abdominal aortic aneurysm	0.000473	0.0335	CbGeAlD
Lovastatin—CYP2C9—blood plasma—abdominal aortic aneurysm	0.000465	0.033	CbGeAlD
Lovastatin—HMGCR—kidney—abdominal aortic aneurysm	0.000436	0.0309	CbGeAlD
Lovastatin—SLCO1B1—kidney—abdominal aortic aneurysm	0.000417	0.0296	CbGeAlD
Lovastatin—CYP3A4—blood plasma—abdominal aortic aneurysm	0.000355	0.0252	CbGeAlD
Lovastatin—CYP2D6—blood plasma—abdominal aortic aneurysm	0.000349	0.0248	CbGeAlD
Lovastatin—SLCO1A2—kidney—abdominal aortic aneurysm	0.00034	0.0241	CbGeAlD
Lovastatin—HMGCR—spinal cord—abdominal aortic aneurysm	0.000339	0.0241	CbGeAlD
Lovastatin—ITGAL—Extracellular matrix organization—LOX—abdominal aortic aneurysm	0.000334	0.0302	CbGpPWpGaD
Lovastatin—ABCC2—kidney—abdominal aortic aneurysm	0.000317	0.0224	CbGeAlD
Lovastatin—HMGCR—Statin Pathway—APOE—abdominal aortic aneurysm	0.000302	0.0273	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—MMP14—abdominal aortic aneurysm	0.000294	0.0266	CbGpPWpGaD
Lovastatin—HMGCR—SREBP signalling—LDLR—abdominal aortic aneurysm	0.000291	0.0264	CbGpPWpGaD
Lovastatin—SLCO1A2—spinal cord—abdominal aortic aneurysm	0.000265	0.0188	CbGeAlD
Lovastatin—ABCB1—blood plasma—abdominal aortic aneurysm	0.000251	0.0178	CbGeAlD
Lovastatin—CYP2C8—kidney—abdominal aortic aneurysm	0.000237	0.0168	CbGeAlD
Lovastatin—CYP3A5—kidney—abdominal aortic aneurysm	0.000214	0.0152	CbGeAlD
Lovastatin—ITGAL—Hemostasis—SELL—abdominal aortic aneurysm	0.000211	0.0191	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—P2RY12—abdominal aortic aneurysm	0.00019	0.0172	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—SELL—abdominal aortic aneurysm	0.000182	0.0165	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—MMP3—abdominal aortic aneurysm	0.000173	0.0157	CbGpPWpGaD
Lovastatin—CYP3A4—kidney—abdominal aortic aneurysm	0.000161	0.0114	CbGeAlD
Lovastatin—CYP2D6—kidney—abdominal aortic aneurysm	0.000158	0.0112	CbGeAlD
Lovastatin—HDAC2—Initiation of transcription and translation elongation at the HIV-1 LTR—NFKB1—abdominal aortic aneurysm	0.000133	0.012	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—NCF1—abdominal aortic aneurysm	0.000124	0.0113	CbGpPWpGaD
Lovastatin—ABCB1—kidney—abdominal aortic aneurysm	0.000114	0.00807	CbGeAlD
Lovastatin—ITGAL—Immune System—SELL—abdominal aortic aneurysm	0.000111	0.01	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—MMP2—abdominal aortic aneurysm	0.000107	0.0097	CbGpPWpGaD
Lovastatin—HMGCR—PPARA activates gene expression—AGT—abdominal aortic aneurysm	0.000106	0.00959	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—SERPINE1—abdominal aortic aneurysm	0.000105	0.00952	CbGpPWpGaD
Lovastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—abdominal aortic aneurysm	0.000104	0.00939	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—AAAS—abdominal aortic aneurysm	9.24e-05	0.00836	CbGpPWpGaD
Lovastatin—ABCB1—spinal cord—abdominal aortic aneurysm	8.86e-05	0.00628	CbGeAlD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—abdominal aortic aneurysm	8.57e-05	0.00775	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—SERPINE1—abdominal aortic aneurysm	8.32e-05	0.00753	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—MMP9—abdominal aortic aneurysm	8.06e-05	0.00729	CbGpPWpGaD
Lovastatin—CYP2C19—Melatonin metabolism and effects—APOE—abdominal aortic aneurysm	7.99e-05	0.00723	CbGpPWpGaD
Lovastatin—HDAC2—Notch Signaling Pathway—NFKB1—abdominal aortic aneurysm	7.92e-05	0.00716	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—abdominal aortic aneurysm	7.85e-05	0.0071	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—NCF1—abdominal aortic aneurysm	7.55e-05	0.00683	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—NOS2—abdominal aortic aneurysm	7.43e-05	0.00672	CbGpPWpGaD
Lovastatin—CYP2D6—Melatonin metabolism and effects—APOE—abdominal aortic aneurysm	7.35e-05	0.00665	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—NFKB1—abdominal aortic aneurysm	7.26e-05	0.00656	CbGpPWpGaD
Lovastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—abdominal aortic aneurysm	7.15e-05	0.00647	CbGpPWpGaD
Lovastatin—HDAC2—Signaling events mediated by HDAC Class I—NFKB1—abdominal aortic aneurysm	7.09e-05	0.00641	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	6.97e-05	0.0063	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—SELL—abdominal aortic aneurysm	6.48e-05	0.00587	CbGpPWpGaD
Lovastatin—HDAC2—Cell Cycle—CDKN2A—abdominal aortic aneurysm	6.47e-05	0.00585	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—abdominal aortic aneurysm	6.44e-05	0.00583	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—SERPINE1—abdominal aortic aneurysm	6.25e-05	0.00566	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—NFKB1—abdominal aortic aneurysm	6.25e-05	0.00565	CbGpPWpGaD
Lovastatin—HDAC2—p75 NTR receptor-mediated signalling—NFKB1—abdominal aortic aneurysm	6.25e-05	0.00565	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	5.96e-05	0.00539	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—P2RY12—abdominal aortic aneurysm	5.84e-05	0.00528	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—MMP2—abdominal aortic aneurysm	5.48e-05	0.00495	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	5.39e-05	0.00487	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—SERPINE1—abdominal aortic aneurysm	5.37e-05	0.00486	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—NFKB1—abdominal aortic aneurysm	5.29e-05	0.00478	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—AGTR1—abdominal aortic aneurysm	5.07e-05	0.00459	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—NFKB1—abdominal aortic aneurysm	4.8e-05	0.00434	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—NOS2—abdominal aortic aneurysm	4.78e-05	0.00432	CbGpPWpGaD
Lovastatin—CYP2C19—Melatonin metabolism and effects—NFKB1—abdominal aortic aneurysm	4.75e-05	0.0043	CbGpPWpGaD
Lovastatin—CYP2D6—Melatonin metabolism and effects—NFKB1—abdominal aortic aneurysm	4.37e-05	0.00395	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	4.1e-05	0.00371	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—SERPINE1—abdominal aortic aneurysm	4.02e-05	0.00364	CbGpPWpGaD
Lovastatin—CYP2C8—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	3.97e-05	0.00359	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—NOS2—abdominal aortic aneurysm	3.76e-05	0.0034	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	3.54e-05	0.0032	CbGpPWpGaD
Lovastatin—CYP2C19—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	3.54e-05	0.0032	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	3.25e-05	0.00294	CbGpPWpGaD
Lovastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—abdominal aortic aneurysm	3.23e-05	0.00292	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	3.22e-05	0.00292	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—abdominal aortic aneurysm	3.17e-05	0.00287	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	3.03e-05	0.00274	CbGpPWpGaD
Lovastatin—HDAC2—Disease—LRP1—abdominal aortic aneurysm	3.02e-05	0.00273	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	2.85e-05	0.00258	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—AAAS—abdominal aortic aneurysm	2.83e-05	0.00256	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	2.79e-05	0.00252	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	2.78e-05	0.00252	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AAAS—abdominal aortic aneurysm	2.75e-05	0.00249	CbGpPWpGaD
Lovastatin—HDAC2—Disease—AAAS—abdominal aortic aneurysm	2.62e-05	0.00237	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—NFKB1—abdominal aortic aneurysm	2.49e-05	0.00225	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—LDLR—abdominal aortic aneurysm	2.4e-05	0.00217	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—NFKB1—abdominal aortic aneurysm	2.3e-05	0.00208	CbGpPWpGaD
Lovastatin—HDAC2—Disease—LDLR—abdominal aortic aneurysm	2.29e-05	0.00207	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—NOS2—abdominal aortic aneurysm	2.28e-05	0.00207	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AAAS—abdominal aortic aneurysm	2.24e-05	0.00203	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NCF1—abdominal aortic aneurysm	2.14e-05	0.00194	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—LRP1—abdominal aortic aneurysm	2.12e-05	0.00191	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—P2RY12—abdominal aortic aneurysm	1.98e-05	0.00179	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—LDLR—abdominal aortic aneurysm	1.96e-05	0.00177	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—SERPINE1—abdominal aortic aneurysm	1.92e-05	0.00174	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	1.91e-05	0.00173	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AAAS—abdominal aortic aneurysm	1.9e-05	0.00172	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	1.72e-05	0.00155	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	1.68e-05	0.00152	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—LDLR—abdominal aortic aneurysm	1.66e-05	0.0015	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AAAS—abdominal aortic aneurysm	1.66e-05	0.0015	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—LDLR—abdominal aortic aneurysm	1.6e-05	0.00145	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	1.6e-05	0.00145	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AAAS—abdominal aortic aneurysm	1.55e-05	0.0014	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	1.52e-05	0.00137	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NCF1—abdominal aortic aneurysm	1.5e-05	0.00136	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	1.47e-05	0.00133	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—LDLR—abdominal aortic aneurysm	1.45e-05	0.00131	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	1.44e-05	0.0013	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	1.43e-05	0.00129	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AAAS—abdominal aortic aneurysm	1.42e-05	0.00128	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—LDLR—abdominal aortic aneurysm	1.35e-05	0.00122	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AAAS—abdominal aortic aneurysm	1.3e-05	0.00118	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	1.3e-05	0.00118	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AGT—abdominal aortic aneurysm	1.27e-05	0.00115	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—APOE—abdominal aortic aneurysm	1.24e-05	0.00112	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—LDLR—abdominal aortic aneurysm	1.24e-05	0.00112	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	1.2e-05	0.00109	CbGpPWpGaD
Lovastatin—HDAC2—Disease—APOE—abdominal aortic aneurysm	1.19e-05	0.00107	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	1.18e-05	0.00107	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	1.15e-05	0.00104	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—LDLR—abdominal aortic aneurysm	1.14e-05	0.00103	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NOS2—abdominal aortic aneurysm	1.11e-05	0.001	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MMP3—abdominal aortic aneurysm	1.07e-05	0.000971	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AGT—abdominal aortic aneurysm	1.03e-05	0.000935	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	1.03e-05	0.000929	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—APOE—abdominal aortic aneurysm	1.01e-05	0.000916	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—SERPINE1—abdominal aortic aneurysm	1e-05	0.000907	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	9.87e-06	0.000893	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AAAS—abdominal aortic aneurysm	9.41e-06	0.000851	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SERPINE1—abdominal aortic aneurysm	9.31e-06	0.000842	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AGT—abdominal aortic aneurysm	8.79e-06	0.000795	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—APOE—abdominal aortic aneurysm	8.61e-06	0.000779	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTGS2—abdominal aortic aneurysm	8.51e-06	0.00077	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AGT—abdominal aortic aneurysm	8.48e-06	0.000767	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	8.45e-06	0.000764	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—APOE—abdominal aortic aneurysm	8.31e-06	0.000751	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	8.27e-06	0.000748	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—LDLR—abdominal aortic aneurysm	8.22e-06	0.000743	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AAAS—abdominal aortic aneurysm	8.15e-06	0.000737	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTGS2—abdominal aortic aneurysm	8.13e-06	0.000735	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AGT—abdominal aortic aneurysm	7.65e-06	0.000692	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	7.54e-06	0.000682	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—APOE—abdominal aortic aneurysm	7.5e-06	0.000678	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	7.39e-06	0.000668	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AAAS—abdominal aortic aneurysm	7.28e-06	0.000658	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AGT—abdominal aortic aneurysm	7.14e-06	0.000646	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—LDLR—abdominal aortic aneurysm	7.12e-06	0.000644	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AAAS—abdominal aortic aneurysm	7.1e-06	0.000642	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—APOE—abdominal aortic aneurysm	7e-06	0.000633	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL2—abdominal aortic aneurysm	6.98e-06	0.000631	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTGS2—abdominal aortic aneurysm	6.94e-06	0.000628	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	6.87e-06	0.000622	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	6.73e-06	0.000609	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AAAS—abdominal aortic aneurysm	6.69e-06	0.000605	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AAAS—abdominal aortic aneurysm	6.63e-06	0.0006	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AGT—abdominal aortic aneurysm	6.55e-06	0.000592	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	6.52e-06	0.00059	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—APOE—abdominal aortic aneurysm	6.41e-06	0.00058	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—LDLR—abdominal aortic aneurysm	6.35e-06	0.000575	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—LDLR—abdominal aortic aneurysm	6.2e-06	0.000561	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AGT—abdominal aortic aneurysm	6.01e-06	0.000543	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTGS2—abdominal aortic aneurysm	5.9e-06	0.000534	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—APOE—abdominal aortic aneurysm	5.89e-06	0.000532	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—LDLR—abdominal aortic aneurysm	5.84e-06	0.000528	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—LDLR—abdominal aortic aneurysm	5.79e-06	0.000524	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	5.67e-06	0.000513	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTGS2—abdominal aortic aneurysm	5.14e-06	0.000465	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	5.06e-06	0.000458	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MMP9—abdominal aortic aneurysm	4.99e-06	0.000452	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	4.94e-06	0.000447	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGS2—abdominal aortic aneurysm	4.8e-06	0.000434	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	4.61e-06	0.000417	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGS2—abdominal aortic aneurysm	4.39e-06	0.000397	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	4.38e-06	0.000396	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AGT—abdominal aortic aneurysm	4.34e-06	0.000393	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—APOE—abdominal aortic aneurysm	4.25e-06	0.000385	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGS2—abdominal aortic aneurysm	4.03e-06	0.000365	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	3.82e-06	0.000345	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AGT—abdominal aortic aneurysm	3.76e-06	0.00034	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APOE—abdominal aortic aneurysm	3.69e-06	0.000333	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AGT—abdominal aortic aneurysm	3.36e-06	0.000304	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APOE—abdominal aortic aneurysm	3.29e-06	0.000298	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AGT—abdominal aortic aneurysm	3.28e-06	0.000296	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APOE—abdominal aortic aneurysm	3.21e-06	0.00029	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AGT—abdominal aortic aneurysm	3.09e-06	0.000279	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AGT—abdominal aortic aneurysm	3.06e-06	0.000277	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APOE—abdominal aortic aneurysm	3.03e-06	0.000274	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APOE—abdominal aortic aneurysm	3e-06	0.000271	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS2—abdominal aortic aneurysm	2.92e-06	0.000264	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS2—abdominal aortic aneurysm	2.52e-06	0.000228	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS2—abdominal aortic aneurysm	2.25e-06	0.000204	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS2—abdominal aortic aneurysm	2.2e-06	0.000199	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS2—abdominal aortic aneurysm	2.07e-06	0.000188	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS2—abdominal aortic aneurysm	2.06e-06	0.000186	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	2.02e-06	0.000183	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	1.98e-06	0.000179	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	1.36e-06	0.000123	CbGpPWpGaD
